ClinicalTrials.Veeva

Menu

Kisspeptin/GPR54 Pathway and Early Puberty

S

Shenzhen Center for Disease Control and Prevention

Status

Completed

Conditions

Puberty, Precocious

Treatments

Other: this study was an observational study and no interventions were given to the participants

Study type

Observational

Funder types

Other

Identifiers

NCT04012632
szCDC_1

Details and patient eligibility

About

There was a worldwide early trend in girls'age for puberty onset. The timing of puberty onset varies greatly among individuals, and much of this variation is modulated by genetic factors. This study was designed to explored the association of polymorphisms in KISS1/GPR54 pathway genes and the risk of early puberty in Chinese Han girls.

Enrollment

628 patients

Sex

Female

Ages

7 to 10 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of central precocious puberty or early and fast puberty.

Exclusion criteria

  • The participants who were not the first visit to the hospital and had been treated before.
  • The participants who were with endocrine disorders.

Trial design

628 participants in 2 patient groups

cases
Description:
Early puberty cases of Han Chinese
controls
Description:
Controls were matched to cases at 1:1 by age (± 3 months)
Treatment:
Other: this study was an observational study and no interventions were given to the participants

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems